On Demand, Antibody Discovery & Development
#01 Antibody Discovery in the Cloud: Using NGS to expand the universe of selectable antibodies (On Demand) Expand #01 Antibody Discovery in the Cloud: Using NGS to expand the universe of selectable antibodies (On Demand) for more informationRegister HereRegister Here #01 Antibody Discovery in the Cloud: Using NGS to expand the universe of selectable antibodies (On Demand)
Collapse #01 Antibody Discovery in the Cloud: Using NGS to expand the universe of selectable antibodies (On Demand)
#02 Ultra-fast development of an anti-COVID-19 antibody (On Demand) Expand #02 Ultra-fast development of an anti-COVID-19 antibody (On Demand) for more informationRegister HereRegister Here #02 Ultra-fast development of an anti-COVID-19 antibody (On Demand)
Collapse #02 Ultra-fast development of an anti-COVID-19 antibody (On Demand)
#03 Deep mining of early antibody response in COVID-19 patients yields potent neutralizers and reveals high level of convergence (On Demand) Expand #03 Deep mining of early antibody response in COVID-19 patients yields potent neutralizers and reveals high level of convergence (On Demand) for more informationRegister HereRegister Here #03 Deep mining of early antibody response in COVID-19 patients yields potent neutralizers and reveals high level of convergence (On Demand)
Collapse #03 Deep mining of early antibody response in COVID-19 patients yields potent neutralizers and reveals high level of convergence (On Demand)
#04 Delivering therapeutic mAbs for COVID-19: What can be done in just one year? (On Demand) Expand #04 Delivering therapeutic mAbs for COVID-19: What can be done in just one year? (On Demand) for more informationRegister HereRegister Here #04 Delivering therapeutic mAbs for COVID-19: What can be done in just one year? (On Demand)
Collapse #04 Delivering therapeutic mAbs for COVID-19: What can be done in just one year? (On Demand)
#05 Staying ahead of the virus: From a multispecies discovery strategy to highly efficacious, clinically suitable multi-antibody cocktails targeting SARS-CoV-2 (On Demand) Expand #05 Staying ahead of the virus: From a multispecies discovery strategy to highly efficacious, clinically suitable multi-antibody cocktails targeting SARS-CoV-2 (On Demand) for more informationRegister HereRegister Here #05 Staying ahead of the virus: From a multispecies discovery strategy to highly efficacious, clinically suitable multi-antibody cocktails targeting SARS-CoV-2 (On Demand)
Collapse #05 Staying ahead of the virus: From a multispecies discovery strategy to highly efficacious, clinically suitable multi-antibody cocktails targeting SARS-CoV-2 (On Demand)
#06 Antibody Fc Engineering: Designing Antibodies for Cancer, Covid-19, and Beyond (On Demand) Expand #06 Antibody Fc Engineering: Designing Antibodies for Cancer, Covid-19, and Beyond (On Demand) for more informationRegister HereRegister Here #06 Antibody Fc Engineering: Designing Antibodies for Cancer, Covid-19, and Beyond (On Demand)
Collapse #06 Antibody Fc Engineering: Designing Antibodies for Cancer, Covid-19, and Beyond (On Demand)
#07 Innovations from the therapeutics antibody space: obligate bispecific antibodies & T cell engagers (On Demand) Expand #07 Innovations from the therapeutics antibody space: obligate bispecific antibodies & T cell engagers (On Demand) for more informationRegister HereRegister Here #07 Innovations from the therapeutics antibody space: obligate bispecific antibodies & T cell engagers (On Demand)
Collapse #07 Innovations from the therapeutics antibody space: obligate bispecific antibodies & T cell engagers (On Demand)
#08 Modeling biologic molecules (On Demand) Expand #08 Modeling biologic molecules (On Demand) for more informationRegister HereRegister Here #08 Modeling biologic molecules (On Demand)
Collapse #08 Modeling biologic molecules (On Demand)
#09 Precision Execution of Bispecifics at Scale from Design to Delivery (On Demand) Expand #09 Precision Execution of Bispecifics at Scale from Design to Delivery (On Demand) for more informationRegister HereRegister Here #09 Precision Execution of Bispecifics at Scale from Design to Delivery (On Demand)
Collapse #09 Precision Execution of Bispecifics at Scale from Design to Delivery (On Demand)
#10 Silence is golden: The importance of attenuating effector functions in therapeutic antibodies (On Demand) Expand #10 Silence is golden: The importance of attenuating effector functions in therapeutic antibodies (On Demand) for more informationRegister HereRegister Here #10 Silence is golden: The importance of attenuating effector functions in therapeutic antibodies (On Demand)
Collapse #10 Silence is golden: The importance of attenuating effector functions in therapeutic antibodies (On Demand)
#11 Understanding memory B cell responses induced by heterologous SARS-CoV-2 exposure (On Demand) Expand #11 Understanding memory B cell responses induced by heterologous SARS-CoV-2 exposure (On Demand) for more informationRegister HereRegister Here #11 Understanding memory B cell responses induced by heterologous SARS-CoV-2 exposure (On Demand)
Collapse #11 Understanding memory B cell responses induced by heterologous SARS-CoV-2 exposure (On Demand)
#12 Best Practices in BLI and its Application in Screening of a Broadly Neutralizing Antibody of Snake Venoms (On Demand) Expand #12 Best Practices in BLI and its Application in Screening of a Broadly Neutralizing Antibody of Snake Venoms (On Demand) for more informationRegister HereRegister Here #12 Best Practices in BLI and its Application in Screening of a Broadly Neutralizing Antibody of Snake Venoms (On Demand)
Collapse #12 Best Practices in BLI and its Application in Screening of a Broadly Neutralizing Antibody of Snake Venoms (On Demand)
#13 Accelerating Antibody Drug Discovery Through Computational Modeling (On Demand) Expand #13 Accelerating Antibody Drug Discovery Through Computational Modeling (On Demand) for more informationRegister HereRegister Here #13 Accelerating Antibody Drug Discovery Through Computational Modeling (On Demand)
Collapse #13 Accelerating Antibody Drug Discovery Through Computational Modeling (On Demand)
#14 Precision high-throughput antibody screening against difficult targets (On Demand) Expand #14 Precision high-throughput antibody screening against difficult targets (On Demand) for more informationRegister HereRegister Here #14 Precision high-throughput antibody screening against difficult targets (On Demand)
Collapse #14 Precision high-throughput antibody screening against difficult targets (On Demand)
#15 Comparing Bispecific Antibody Format Feasibility (On Demand) Expand #15 Comparing Bispecific Antibody Format Feasibility (On Demand) for more informationRegister HereRegister Here #15 Comparing Bispecific Antibody Format Feasibility (On Demand)
Collapse #15 Comparing Bispecific Antibody Format Feasibility (On Demand)
#16 Multiple Innovative Technologies & Platforms Empower Antibody Discovery (On Demand) Expand #16 Multiple Innovative Technologies & Platforms Empower Antibody Discovery (On Demand) for more informationRegister HereRegister Here #16 Multiple Innovative Technologies & Platforms Empower Antibody Discovery (On Demand)
Collapse #16 Multiple Innovative Technologies & Platforms Empower Antibody Discovery (On Demand)
#17 Versatility of Modular Antibodies: From Rapid Format Switch to Fast Screening of Libraries and Bispecifics (On Demand) Expand #17 Versatility of Modular Antibodies: From Rapid Format Switch to Fast Screening of Libraries and Bispecifics (On Demand) for more informationRegister HereRegister Here #17 Versatility of Modular Antibodies: From Rapid Format Switch to Fast Screening of Libraries and Bispecifics (On Demand)
Collapse #17 Versatility of Modular Antibodies: From Rapid Format Switch to Fast Screening of Libraries and Bispecifics (On Demand)
#18 Strategies for Mitigating the Unpredictability of Fc-Mediated Functions in Antibody Development (On Demand) Expand #18 Strategies for Mitigating the Unpredictability of Fc-Mediated Functions in Antibody Development (On Demand) for more informationRegister HereRegister Here #18 Strategies for Mitigating the Unpredictability of Fc-Mediated Functions in Antibody Development (On Demand)
Collapse #18 Strategies for Mitigating the Unpredictability of Fc-Mediated Functions in Antibody Development (On Demand)
#19 IgE Class Antibody Therapeutics for Cancer (On Demand) Expand #19 IgE Class Antibody Therapeutics for Cancer (On Demand) for more informationRegister HereRegister Here #19 IgE Class Antibody Therapeutics for Cancer (On Demand)
Collapse #19 IgE Class Antibody Therapeutics for Cancer (On Demand)
#20 3D antibody modeling in Orion (On Demand) Expand #20 3D antibody modeling in Orion (On Demand) for more informationRegister HereRegister Here #20 3D antibody modeling in Orion (On Demand)
Collapse #20 3D antibody modeling in Orion (On Demand)
#21 Harnessing the power of antibody-drug conjugates: How the Signal's Research Suite advances multi-modal drug development (On Demand) Expand #21 Harnessing the power of antibody-drug conjugates: How the SignalRegister HereRegister Here #21 Harnessing the power of antibody-drug conjugates: How the Signal
Collapse #21 Harnessing the power of antibody-drug conjugates: How the Signal
#22 Harnessing Divergent Species to Access Difficult and Conserved Antibody Targets (On Demand) Expand #22 Harnessing Divergent Species to Access Difficult and Conserved Antibody Targets (On Demand) for more informationRegister HereRegister Here #22 Harnessing Divergent Species to Access Difficult and Conserved Antibody Targets (On Demand)
Collapse #22 Harnessing Divergent Species to Access Difficult and Conserved Antibody Targets (On Demand)
#23 Advancing early-stage bispecific discovery programs towards clinical success, with GS Discovery and bYlok technology (On Demand) Expand #23 Advancing early-stage bispecific discovery programs towards clinical success, with GS Discovery and bYlok technology (On Demand) for more informationRegister HereRegister Here #23 Advancing early-stage bispecific discovery programs towards clinical success, with GS Discovery and bYlok technology (On Demand)
Collapse #23 Advancing early-stage bispecific discovery programs towards clinical success, with GS Discovery and bYlok technology (On Demand)
#24 Accelerating Antibody Drug Discovery with Fully Human Antibody Mouse HUGO-Ab and High-Throughput Single B Cell Screening (On Demand) Expand #24 Accelerating Antibody Drug Discovery with Fully Human Antibody Mouse HUGO-Ab and High-Throughput Single B Cell Screening (On Demand) for more informationRegister HereRegister Here #24 Accelerating Antibody Drug Discovery with Fully Human Antibody Mouse HUGO-Ab and High-Throughput Single B Cell Screening (On Demand)
Collapse #24 Accelerating Antibody Drug Discovery with Fully Human Antibody Mouse HUGO-Ab and High-Throughput Single B Cell Screening (On Demand)
#25 Avoid Thy Neighbor: Antibody Discovery Lessons from Successful LILRB1/LILRB2 Targeted Myeloid Suppression Expand #25 Avoid Thy Neighbor: Antibody Discovery Lessons from Successful LILRB1/LILRB2 Targeted Myeloid Suppression for more informationRegister HereRegister Here #25 Avoid Thy Neighbor: Antibody Discovery Lessons from Successful LILRB1/LILRB2 Targeted Myeloid Suppression
Collapse #25 Avoid Thy Neighbor: Antibody Discovery Lessons from Successful LILRB1/LILRB2 Targeted Myeloid Suppression